Actualités
Séminaires

Vendredi 18 Octobre 2024 de 14h00 à 15h15
SEMINAIRE EXTERNE IRCM


Borhane GUEZGUEZ

Department Hematology and Medical Oncology, University Medical Center Mainz, Germany

"Advancing Cancer Therapy in Leukemia : The Intersection of Epigenetics, Inflammation and Tumor Microenvironment"

host : Alexandre Djiane (IRCM)


Vendredi 25 Octobre 2024 de 11h00 à 12h15
SEMINAIRE EXTERNE IRCM


Eileen PARKES

Associate Professor,

Innate tumor Immunology laboratory

Oxford University, England

"Targeting immunosuppression in Chromosomally unstable cancers"

Dr Eileen Parkes is an early phase medical oncologist and associate professor at the University of Oxford. She completed her medical oncology training and PhD at Queens University Belfast before moving to Oxford in 2019. She leads early phase studies of novel IO, including STING agonsits, and is lead for Oxford Experimental Cancer Medicine Centre, focusing on translational research. Her lab team studies the tumour microenvironment of chromosomally unstable cancers, with a particular focus on cGAS-STING signalling, intending to identify novel therapeutic strategies for chromosomally unstable cancers including oesophageal adenocarcinomas.

host: Julien Faget (IRCM)


Vendredi 08 Novembre 2024 de 14h00 à 15h15
SEMINAIRE EXTERNE IRCM


Gilles PAGES

Université Cote d'Azur,

Institut de Recherche Cancer et Vieillissement de Nice (IRCAN)

UMR CNRS 7284/U Inserm 1081

"From the discovery of mechanisms of resistance to conventional therapies to the establishment of innovative treatments for metastatic kidney cancers"

hôte : Alexandre DAVID (IRCM)


Vendredi 15 Novembre 2024 de 14h00 à 15h00
SEMINAIRE EXTERNE IRCM


Ewan MacDonald

Centre de Recherche en Biologie Cellulaire de Montpellier (CRBM)
Equipe "Dynamique du Cytosquelette et du Trafic Membranaire dans l'Adhérence"

CNRS UMR 5237

"Membrane trafficking controls invasive cell migration of triple negative breast cancer cells"

Hôte : Nathalie Bonnefoy (IRCM)

 


Vendredi 29 Novembre 2024 de 14h00 à 15h30
SEMINAIRE IRCM vendredi 29 Novembre 14h


Bassam Janji, PhD

Group Leader, Tumor Immunotherapy and Microenvironment

Luxembourg Institute of Health, Department of Cancer Research

"Breaking the Shield: Innovative Approaches to Overcome the Immunosuppressive Tumor Microenvironment and Improve Cancer Immunotherapy."

contact : Andrei Turtoi (IRCM)


Vendredi 11 Avril 2025 de 14h00 à 15h15
SEMINAIRE EXTERNE IRCM


Raphael J. Morscher

Pediatric Cancer Metabolism Laboratory, Children's Research Center,

University of Zurich, 8032 Zurich, Suisse

"Reprogramming neuroblastoma translation by diet-enhanced polyamine depletion"

hôte : Alexandre DAVID (IRCM)


Jeudi 03 Octobre 2024 de 10h30 à 12h00
SEMINAIRE EXTERNE IRCM


Mickaël Le Clech, PhD

Business Developer


ENSCM-USCBF-CN

"Discover your drug candidate with ChemBioFrance and the French National Chemical Library"

host : Eric JULIEN (IRCM)


Jeudi 26 Septembre 2024 de 15h00 à 16h30
SEMINAIRE EXTERNE IRCM "exposUM"


Mircea SOFONEA

Associate professor of epidemiology, University of Montpellier & CHU Nîmes

PCCEI (UM, Inserm, EFS) research unit

Research head of the ExposUM Institute

"On Airbone Transmission : history, biophysics, epidemiology & modeling"

Airborne transmission was an emblematic point of tension during the COVID pandemic. From its identification to its prevention, it represents both a scientific and a health issue. In this lecture, we will draw on recent reviews and key works in the literature, while situating older sources in the evolution of points of view on the subject, in an attempt to summarise the main historical, biophysical and epidemiological elements relating to airborne transmission, with an emphasis on the contributions of modelling to the study of this subject, now a public health priority.

Noted of, the scientific seminar will be followed by an institutional presentation of the ExposUM Institute.

host : Antonio MARAVER (IRCM)



© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés